SEC Filings

S-1
AVEXIS, INC. filed this Form S-1 on 01/15/2016
Entire Document
 

 

EXHIBIT B
TECHNICAL INFORMATION TRANSFER

 

Within **** of the Effective Date, Children’s must transfer or provide Licensee with copies of or access to the following Technical Information:

 

·                  The Investigational New Drug application for **** (the “IND”)

·                  Copies of records, data, results, reports, documents, protocols, forms, presentations, papers, applications, pertinent correspondence with federal agencies and contracted third parties, and standard operating procedures related to the IND, including pre-clinical studies

·                  ****.

·                  Copies of records, data, results, reports, documents, protocols, forms, presentations, papers, applications, correspondence with federal agencies and contracted third parties, and standard operating procedures related to intrathecal delivery of ****, including pre-clinical studies

·                  Copies of patent applications as filed, patent office related correspondence, and invoices from contracted third parties related to the Licensed Patents

 


****CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

 

24



© AveXis, Inc. All Rights Reserved.